Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?

PURPOSE: To evaluate the use of high-dose radiotherapy using carbon ions (C12) on non-adenoid cystic malignant salivary gland tumors (MSGT). PATIENTS AND METHODS: Between 2009 and 2013, patients with biopsy-proven non-ACC MSGT histologies of the head and neck received a combined regimen of IMRT plus...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, A. D., Poulakis, M., Vanoni, V., Uhl, M., Chaudhri, N., Federspil, P. A., Freier, K., Krauss, J., Debus, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936021/
https://www.ncbi.nlm.nih.gov/pubmed/27386864
http://dx.doi.org/10.1186/s13014-016-0657-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936021/
https://www.ncbi.nlm.nih.gov/pubmed/27386864
http://dx.doi.org/10.1186/s13014-016-0657-z

Ejemplares similares